Multimycotoxin analysis in urines to assess infant exposure: a case study in Cameroon by Njumbe Ediage, Emmanuel et al.
1 
 
 
 
biblio.ugent.be 
 
The UGent Institutional Repository is the electronic archiving and dissemination platform for all 
UGent research publications. Ghent University has implemented a mandate stipulating that all 
academic publications of UGent researchers should be deposited and archived in this repository. 
Except for items where current copyright restrictions apply, these papers are available in Open 
Access. 
 
This item is the archived peer-reviewed author-version of: 
Title: MULTIMYCOTOXIN ANALYSIS IN URINES TO ASSESS INFANT EXPOSURE: A CASE STUDY IN 
CAMEROON 
Authors: Emmanuel Njumbe Ediage1, Jose Diana Di Mavungu1, Suquan Song1, Isabelle Sioen2, Sarah 
De Saeger1 
In: Environmental International, 57-58, 50-59, 2013. 
 
To refer to or to cite this work, please use the citation to the published version: 
Emmanuel Njumbe Ediage, Jose Diana Di Mavungu, Suquan Song, Isabelle Sioen, Sarah De Saeger. 
2013. MULTIMYCOTOXIN ANALYSIS IN URINES TO ASSESS INFANT EXPOSURE: A CASE STUDY IN 
CAMEROON. Environmental International, 57-58, 50-59.  
http://dx.doi.org/10.1016/j.envint.2013.04.002 
 
 
 
 
 
 
2 
 
MULTIMYCOTOXIN ANALYSIS IN URINES TO ASSESS INFANT 
EXPOSURE: A CASE STUDY IN CAMEROON 
Emmanuel Njumbe Ediage
1
, Jose Diana Di Mavungu
1
, Suquan Song
1
, Isabelle Sioen
2
, Sarah 
De Saeger
1
 
1
Laboratory of Food Analysis, Ghent University, Harelbekestraat 72, 9000, Ghent, Belgium. 
2
Department of Public Health, Faculty of Medicine and Health Sciences, Ghent University, 
De pintelaan 185, Block A-2, Ghent, Belgium. 
 
*Corresponding author: Tel: +3292648133; Fax: +3292648199. Email 
emmanuel.njumbeediage@ugent.be 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
ABSTRACT 
This study was conducted to investigate mycotoxin exposure in children (n=220, aged 1.5-4.5 
years) from high mycotoxin contamination regions of Cameroon and to examine the 
association between the mycotoxin levels (in total 18 analytes) and several socio-demographic 
factors and anthropometric characteristics. A cross-sectional study was conducted in six 
villages in Cameroon with 220 children. Mycotoxins and their metabolites were detected in 
160/220 (73%) urine samples. 
There were significant differences in the mean contamination levels of ochratoxin A (p = 
0.01) and β-zearalenol (p = 0.017) between the two agro-ecological zones investigated. 
Likewise significant differences were observed in the mean levels of aflatoxin M1 (p = 0.001) 
across the weaning categories of these children. The mean concentration of aflatoxin M1 
detected in the urine of the partially breastfed children (1.43 ng/mL) was significantly higher 
(p = 0.001) than those of the fully weaned children (0.282 ng/mL).  
Meanwhile, the mean concentrations of deoxynivalenol (3.0 ng/mL) and fumonisin B1 (0.59 
ng/mL) detected in the urine of the male children was significantly (p value 0.021 for 
deoxynivalenol and 0.004 for fumonisin B1) different from the levels detected in the urine of 
female children; 0.71 ng/mL and 0.01 ng/mL for deoxynivalenol and fumonisin B1 
respectively. In this study, there was no association between the different malnutrition 
categories (stunted, wasting and underweight) and the mycotoxin concentrations detected in 
the urine of these children. 
However, there is sufficient evidence to suggest that children in Cameroon under the age 5 are 
exposed to high levels of carcinogenic substances such as fumonisin B1, aflatoxin M1 and 
ochratoxin A through breastfeeding. To the best of our knowledge, this is the first report of its 
kind carried out in West Africa to determine multi-mycotoxin exposure in infants.  
Key words: mycotoxins, biomarkers, children, urine, weaned, breastfeeding 
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1.1 Introduction 
The environment of children during early development (from in utero to 36 months) is critical 
for disease and risk in later life. Children are uniquely vulnerable to environmental toxicants 
because of their greater relative exposure, less developed metabolism, and higher rates of cell 
division, growth, and development (Makri et al., 2004). The environmental insults of 
childhood may manifest themselves over a lifetime of growth to adulthood and senescence. In 
addition to physiologic vulnerabilities, children may have great social vulnerabilities as well 
as poverty and malnutrition. In most third world countries especially in Sub-Saharan Africa 
(SSA), many children are not only malnourished, but they are also chronically exposed to 
high levels of toxic fungal metabolites (mycotoxins) in their diet (Cardwell et al., 2004). The 
fact that developmental exposure to agents such as mycotoxins produces effects that differ 
qualitatively and quantitatively from those produced by adult exposure, represents a major 
empirical and conceptual foundation for child health risk assessment (NAS, 1993; Carlson, 
1998).  
Traditionally, mycotoxin exposure in humans has been assessed by detecting the presence of 
the mycotoxins in food commodities (Song et al. (in press)). This approach is generally 
considered less accurate since the mycotoxins are not homogeneously distributed within any 
given food commodity (Bennett and Klich, 2003; Scott and Trucksess, 1997; Tanaka et al., 
2010). Secondly, there are some other routes through which individuals can be exposed to 
mycotoxins such as physical contact through the skin and inhalation. Furthermore, in case of 
disease outbreak for which mycotoxin exposure was suspected, the food is most often no 
longer available for analysis. As a result, the traditional evaluation method is only suitable to 
assess the exposure of populations to some toxins or to identify possible risk groups. It cannot 
really reflect accurate information on the individual intake of mycotoxins (Kuiper-Goodman, 
1999). 
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In order to circumvent the above mentioned shortcomings, biomarkers have been proposed as 
a suitable alternative. Recent developments in molecular biology and instrumentation have 
provided new tools for use in environmental health care research and biological risk 
assessment. Biomarkers have the potential to be quantitative dosimeters of individual 
exposure and biologic effective dose, as well as early warning signals of biologic effect 
(Montesano et al., 1997; Ramjee et al., 1992; Riley and Pestka, 2005; Turner et al., 2000; 
WHO, 2001; Wild and Gong, 2010). 
Prior to this study, these same authors investigated mycotoxin contamination in three 
agricultural staples (maize, peanuts and cassava) from three agro-ecological zones of 
Cameroon over two seasons (July-August 2009 (season 1) and December-January 2010-2011 
(season 2)). Data form this survey revealed a high mycotoxin contamination rate in two of the 
three agro-ecological regions. A summary of the contamination data is presented in Table 1.  
The aim of this study was to investigate the relationship between some anthropometric  data 
as well as dietary habits and mycotoxin exposure in these children in order to better 
understand the causes of exposure and to be able to set-up effective prevention campaigns. Up 
till now, most mycotoxin exposure assessments in developing countries have focused on the 
aflatoxins (AFs) and fumonisin B1 (FB1). Moreover, for aflatoxin exposure, aflatoxin-albumin 
adduct is usually the target metabolite in blood. Obtaining blood samples from younger 
children (< 5 years) creates a high barrier for participation. It was for this reason that urine 
was chosen as target matrix. It was therefore our objective to push beyond the frontiers and 
include some other analytes such as citrinin (CIT), zearalenone (ZEN), ochratoxin (OTA), 
deoxynivalenol (DON), T2-toxin (T2) and their metabolites which are frequent contaminants 
of food and which have so far not been investigated. The choice of the different mycotoxin 
metabolites (potential biomarkers) for the different analytes was based on toxicokinetics data 
extracted from the literature as recently described by Njumbe Ediage et al. (2012). 
6 
 
1.2 Materials and methods 
1.21 Reagents and materials 
LC-MS grade methanol, high performance liquid chromatography (HPLC) grade acetonitrile, 
methanol and n-hexane were purchased from VWR International (Zaventem, Belgium). Bond 
Elut strong anion exchange (SAX) SPE cartridges were obtained from Varian (Sint-Katelijne 
Waver, Belgium). Water was purified on a Milli-Q Plus apparatus (Millipore, Brussels, 
Belgium).  
 
1.2.2 Standards 
 
Mycotoxin-reference standards and metabolites namely aflatoxin B1 (AFB1), HT-2 toxin (HT-
2), OTA, ZEN, FB1, deepoxy-deoxynivalenol (DOM), CIT, alpha zearalenol (α-ZOL) and 
beta zearalenol (β-ZOL), were purchased from Sigma-Aldrich (Bornem, Belgium). T-2 toxin 
was purchased from Biopure (Tulln, Austria). DON and aflatoxin M1 (AFM1) were purchased 
from Fermentek (Jerusalem, Israel). Ochratoxin alpha (OT) was obtained from Coring 
System Diagnostix (Gernsheim, Germany). 4 hydroxy OTA (4-OH OTA) was a gift from 
Professor Ralf Blank (Institute of Animal Nutrition and Physiology, Kiel, Germany). Stock 
solutions of DON, AFM1, AFB1, HT-2 toxin, T-2 toxin, OTA, ZEN, FB1, CIT, α-ZOL and β-
ZOL were prepared in methanol at a concentration of 1 mg/mL.  DOM and OT were 
obtained as solutions, 100 μg/mL and 10.3 μg/mL respectively in acetonitrile. DON-3Glu was 
synthesized using the protocol described by Wu et al. (2007) while AFB1-N7-guanine adduct 
(AFB1-N7Gua) was prepared using the procedure described in Egner et al. (2006). 
Hydrolyzed FB1 (HFB1 or aminopentol) was synthesized by alkaline hydrolysis as described 
in Pagliuca et al. (2005). ZEN-Glu was obtained as a gift from Dr. Alfons Callebaut 
(Veterinary and Agrochemical Research Center, Tervuren, Belgium) 
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1.2.3 Participants recruitment  
 
Two agro-ecological zones were targeted and this included the humid forest with monomodal 
rainfall (HFM) and the western highland (WH) of Cameroon. The selection of these two 
zones was based on an earlier study which revealed a high occurrence of mycotoxins in three 
different dietary staples (maize, peanuts and cassava) originating from these two zones. An 
overview of the contamination data for the different (three) agro-ecological zones is presented 
in Table 1. From each of the target (two) agro-ecological zones, a region was selected. These 
agro-ecological zones can also be referred to as the Northwest and Southwest regions 
representing the HFM and WH regions respectively. Three villages within each of these two 
regions were chosen on the grounds there exists a health center in the village or that the health 
center was within the nearest 15 km. This was to reduce the time between sample collection 
and storage since most of the selected villages were situated in very remote areas of the 
country. The villages include Anta (ANTA), Baga (BB) and Bmanya (BM) representing the 
Northwest region while Diffa (DIFFA), BGwana (BGN) and Kake (KII) represented the 
Southwest region. A schematic view of the map of Cameroon, showing the geographical 
location of the studied villages is represented in framework in Figure 1. 
Ethical approval and clearances for this study were obtained from the Ministry of Public 
Health in Cameroon to cover the two regions. Another ethical approval was obtained from 
Ghent University. Forty children per village (in total 240 children), aged 1.5 to 4.5 years, 
were envisaged for recruitment with the inclusion of one child per household. Children on 
medication or having medical record of kidney or metabolic problems were excluded from the 
study. The parents or guardians of the selected children were informed about the nature of the 
study. During the information session, the objectives were clearly read out in the presence of 
the mother and the child and also in the presence of some local interpreters in cases where the 
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mother was not well educated to understand the language of the informant. A day or two was 
allowed for the parents or guardian to decide on their participation in the project. Once they 
agreed to participate, they were asked to sign an informed consent form. The fieldwork for the 
study (sample and questionnaire collection) took place in March 2012.  
 
1.2.4 Questionnaire 
 
A questionnaire was administered by trained interviewers (nurses of the health centers). The 
information collected from the children included age, gender, weaning status, type of long 
term or short term illnesses. Concerning the parent or guardian, information on the age and 
weight of the mother, socioeconomic status such as the level of education of the mother, 
occupation of the mother, average monthly income of the mother and specific food choices 
were recorded. A lot of concern was placed on the parent or guardian status because it was 
seen as more relevant to the nutrition and wellbeing of the child. The educational status of the 
mother was classified into three categories: no school education, primary school education or 
secondary school education. The food consumption details of the entire family were also 
recorded. The parent or guardian was asked to indicate which of the three staples (maize, 
peanut and cassava) was most frequently used to prepare the family meal, if the staples were 
locally produced or were bought from the local markets, the type of processing carried out, 
the frequency of consumption by the family on a weekly basis of the selected staples, and the 
number of times per day that the same staples was eaten by the child.  
A 24h dietary recall was also performed where by all the main and minor ingredients used in 
preparing the home meal were clearly listed so as to identify the possible route(s) of 
contamination and/or exposure of the child(ren) concerned. 
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1.2.5 Age, weight and height measurements 
 
The ages of both the parents and/or guardian and children were extracted from official birth 
certificates. The weight and height of all the children were measured using accurately 
calibrated instruments (electronic scales: Soehnle, max wt 40 kg, accurate 10g; height 
measurement SCHORR, Maryland, USA). From the recorded heights and weights, three types 
of calculations were performed namely the weight for age Z-score (WAZ), the height for age 
Z-score (HAZ) and weight for height score (WHZ) according to the recommendation of the 
World Health Organisation Multicentre Growth Reference Study Group (WHO, 2006). 
According to this WHO criteria, a Z-value of < -2 for any of these criteria (WAZ and HAZ) is 
recognized as malnutrition and < -3 as severe malnutrition. Meanwhile a WHZ score reflects 
the body shape, where a low value is indicative of wasting and acute malnutrition . The height 
and weight measurements were carried out by nurses who were all qualified health personnel. 
1.2.6 Urine sample collection and multi-mycotoxin analysis 
 
First morning void urine was demanded from all volunteers. A 60 mL urine recipient was 
distributed to each of the participating child a day prior to the day of sample collection. Urine 
samples were frozen within six hours after collection. In some cases, urine samples were 
rejected if it took more than 6hr from the time of collection to the time of storage (freezing at 
-20
o
C). Stability studies carried out prior to this survey by this same group of researchers 
revealed that the target analytes were stable for 12hr at 25°C post-collection (Njumbe Ediage 
et al., 2012). All samples were later preserved in dry ice (-56°C) and transported to the 
Laboratory of Food Analysis, Ghent University, Belgium by airway. 
In total 220 samples met the strict specifications of collection and storage and were analyzed. 
A 10 mL urine was used for mycotoxin analysis. All samples were analyzed by using a 
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validated liquid chromatography tandem mass spectrometry (LC-MS/MS) method previously 
described by Njumbe Ediage et al. (2012) using liquid-liquid extraction (LLE) in combination 
with SAX SPE clean-up.  
 
1.2.7 Statistical Analysis 
 
Where the urinary analyte was not quantifiable, middle value between zero and the analyte 
limit of quantification was used. The data were not normally distributed, hence equal variance 
was not assumed. Non parametric tests such as Mann-Whitney U and Kruskal Wallis tests 
were performed to investigate possible associations or differences between the mycotoxins 
concentrations and the age groups, gender, weaning status and agro-ecological zones. All the 
analyses were performed using SPSS Software version 20.0 (SPSS Inc., Chicago, IL, USA). 
Statistical significance was set at p<0.05.  
 
1.3 Results 
1.3.1 Descriptive data on the characteristics and staple foods of the children  
 
Demographic data for the 220 children are presented by village in Table 2. With respect to 
gender, BGwana had the least number of males (n=4) which was significantly different from 
the other villages (average n=24). The fact that BGwana had the smallest population recruit 
(n=14) compared to the other villages (average n=41) can explain the fewer number of male 
recruit. However, there were no statistical differences in the mean age distribution across the 
six villages (p > 0.05).  
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With respect to the weaning status, the children were classified in three categories as follows: 
wholly breastfed, partially breastfed or fully weaned (i.e. no breast milk). The distribution 
(percentage) of the children within the different breastfeeding categories for entire sample 
population was as follows: wholly breastfed 15%, partially breastfed 25%, while 60% were 
fully weaned. Meanwhile Table 2 also shows the percentage of totally weaned and wholly 
breastfed children for the six different villages. In most villages, children ≥ 2 years were 
either partially breastfed or fully weaned. Each parent/guardian was asked through the 
questionnaire to indicate which of the three staples (maize, peanuts and cassava) was mostly 
used to prepare the family meal. Only one of the three staples could be selected from the list. 
Maize was used as the main ingredient by 34% of the participants on a weekly basis to 
prepare the family. For cassava, 50% indicated that this staple was frequently used on a 
weekly basis while only 16% of the households indicated the use of peanuts as the main 
ingredient. Table 2 further illustrates per village, the number of households who indicated the 
use of one of these staples on a weekly basis to the total number of households recruited from 
that particular village.  
Significant differences in the consumption pattern for maize, cassava and peanuts were 
observed across the two agro-ecological zones. In the Northwest region representing the 
western highland, 67/126 (53%) of the participants indicated that maize was used as the main 
staple on a weekly basis, while for the Southwest region only 8/94 (9%) of the households 
used maize as the main staple. With respect to cassava consumption, 44/126 (34%) of the 
households from the Northwest region indicated cassava as the main ingredient in the family 
meal as against 70% (66/94)  for households from the Southwest region (Table 2). 
In general peanuts were never considered as the main ingredient for the family meal. Only 
15/126 (12%) households from the Northwest region indicated the use of peanuts to prepare 
the family meal as against 21% for the households of the Southwest region (Table 2). 
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Table 3 shows the prevalence of malnutrition in the children population recruited for this 
study. There was a strong prevalence of stunted growth (low HAZ), low weight for age Z-
score (WAZ) and wasting in 39%, 37% and 23% respectively of the children according to the 
World Health Organization 2006 criteria (WHO, 2006). The mean values for each of the three 
growth parameters WAZ, HAZ and WHZ were below zero (mean = -1.63, -1.1, -1.36, 
respectively) with particularly low values for WAZ and WHZ. An average of 17% of the 
children had a Z-score of < -3 in at least one parameter, a situation regarded as extreme 
malnutrition by WHO criteria.  
A great majority (85%) of the parents/guardian had only primary school education and this 
was reflected in their average monthly income which was less than 50 United States dollar 
(USD).  
 
1.3.2 Distribution of mycotoxin contamination and co-occurrence rate in the urine samples 
 
Mycotoxins were detected in 160/220 (73%) of the samples analyzed. The analytes 
investigated and their corresponding limit of detection (LOD) were as follows; AFB1 (0.83 
ng/mL), CIT (2.88 ng/mL), T-2 toxin (T-2, 0.05 ng/mL), HT-2 toxin (HT-2; 0.42 ng/mL), 
HFB1 (0.51 ng/mL), DOM (0.65 ng/mL), aflatoxin AFB1-N7Gua (0.85 ng/mL), OTA (0.03 
ng/mL), OTα (0.03 ng/mL), 4-OH OTA (0.12 ng/mL), DON (0.04 ng/mL), AFM1 (0.01 
ng/mL), FB1 (0.01 ng/mL), ZEN (0.1 ng/mL), β-ZOL (0.01 ng/mL), α-ZOL (0.31 ng/mL), 
DON-3Glu (2.25 ng/mL) and ZEN-Glu (3.65 ng/mL).  
Seven of the 18 analytes investigated were detected in one or more samples. The analytes 
included OTA, DON, AFM1, FB1, ZEN, β-ZOL and α-ZOL. The occurrence frequency for the 
detected analytes were as follows: OTA (32%), DON (17%), AFM1 (14%), FB1 (11%), β-
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ZOL (8%), ZEN (4%), α-ZOL (4%) and DON-3Glu (1%). Data regarding the individual 
mycotoxin concentration were further investigated in terms of co-occurrence in the samples 
analyzed. The co-occurrence rate of 2, 3 and 4 co-occurring mycotoxins per sample was 35%, 
5% and 5% respectively.  
 
1.3.3 Correlation between the different urinary concentrations and socio-demographic factors 
and anthropometric characteristics 
 
A Mann-Whitney test revealed significant differences in OTA (p = 0.01) and β-ZOL (p = 
0.017) mean concentrations between the two agro-ecological regions. For both mycotoxins, 
the mean concentrations detected in children from the Northwest region (0.25 ng/mL and 1.82 
ng/mL for OTA and β-ZOL respectively) were significantly higher than those from the 
Southwest region (0.16 ng/mL and 0.31 ng/mL for OTA and β-ZOL respectively). For the 
other mycotoxins, no significant differences in the mean concentrations were observed 
between the two regions. A pairwise comparison of the mycotoxin concentration for the 
individual villages was further computed. Again, a Kruskal-Wallis test revealed significant 
differences in OTA (p = 0.008) and FB1 (p = 0.003) concentrations across the different 
villages. The boxplots of Figure 1 show the distribution of each of these toxins for the 
different villages, while Table 4 highlights which of the villages were significantly different 
from the others as indicated by the p values. All villages were compared pairwise. 
A more critical insight analysis of the data was performed in order to exploit the possible 
correlation/associations between the different analyte concentrations and some socio-
demographic factors. Table 5 shows the geometric mean concentration, the minimum and 
maximum concentration of each analyte for the different demographic categories. Meanwhile, 
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the mean concentrations of DON and FB1; 3.0 ng/mL and 0.59 ng/mL respectively detected in 
the urine of the male children was significantly (p value 0.021 for DON and 0.004 for FB1) 
different from the levels detected in the urine female children; 0.71 ng/mL and 0.01 ng/mL for 
DON and FB1 respectively. 
The mean concentration of the different mycotoxins was statistically the same across the 
different age group categories (p > 0.05). To perform this comparison, the children were 
classified into four groups based on their ages: group 1 comprised of children between 1 to < 
2 years, group 2 was made up of children between 2 to < 3 years, children between 3 to < 4 
years were placed in group 3, while group 4 was made of children older than 4 years but less 
than 5 years old.  
A Kruskal Wallis test was performed to investigate possible differences between the 
respective mean mycotoxin concentrations and the different malnutrition and weaning 
categories. No differences were observed between the mean concentrations of the analytes 
and being underweight (low WAZ), wasted (low WHZ) or stunted (low HAZ) (p > 0.05). 
However, significant differences were observed between the weaning categories of the 
children and mean AFM1 concentrations detected in the urine. The mean AFM1 concentration 
detected from the fully weaned children (0.282 ng/mL) was significant different from those 
who were partially breastfed (mean concentration 1.43 ng/mL, p = 0.035) and wholly 
breastfed (mean 0.69 ng/mL, p = 0.001). There were no significant differences in the mean 
AFM1 concentration between the wholly breastfed and the partially weaned children (p = 
0.226). Exposure was highest in the partially breastfed group while the fully weaned infants 
had the least AFM1 contamination.  
However, there were no significant differences in the mean OTA, DON, FB1, ZEN, α-ZOL 
and β-ZOL concentrations detected in the urine samples across the different weaning 
categories.  
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1.4 Discussion 
 
The order of occurrence (%) of the analytes OTA (32%), AFM1 (14%), FB1 (11%) in samples 
from Cameroon was the same to those reported in a similar study carried out with Sri Lanka 
adult population (Desalegn et al. 2011). This convergence of results could be due to similar 
occurrence pattern of the parent toxins in foodstuffs native to these countries; taking into 
consideration that both countries are situated within the same latitude (0-10°N).  
 
The differences in the urinary concentrations of DON and FB1 between the male and female 
children could be due to a random occurrence or the fact that males in general eat more than 
females and hence they are more exposed. However, this necessitates further studies before 
any definite conclusion(s) can be made. Any conclusion drawn at this phase of the research 
might be misleading. 
Since there were differences in food preferences between the two agro-ecological zones 
(highlighted in Table 2), it was anticipated that this could result in differences in the 
mycotoxin contamination pattern in the urine of children from these two agro-ecological 
zones. While FB1, AFB1, DON, and ZEN (in that order) are said to be the most frequent 
contaminants in cereals from SSA (e.g. maize) (Njobeh et al., 2010), AFB1 is a common 
contaminant in peanuts and cassava products. OTA is more of a contaminant in peanut 
products (Njumbe Ediage et a1., 2011) than in products derived from the other two food 
matrices (maize and cassava flour). Despite the high frequency of consumption of peanuts for 
households from the Southwest region (20/94) than those from the Northwest region (15/126) 
(Table 2) and the 70% occurrence rate of OTA in urine of children from two villages (Kake 
and BGwana) in the Southwest region, the mean concentration of OTA detected in urine of 
children from the Northwest region was significantly higher than those from the Southwest 
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region (p = 0.01). This observation raises questions regarding other dietary sources which 
contributed significantly to the urinary levels of OTA other than peanuts. Hence there is need 
for further investigation to identify the other possible sources of OTA exposure across the 
studied communities. However, the occurrence rate of OTA in the urine samples from the 
other villages was less than 20%. 
Investigations carried out on human biological fluids have shown that OTA contamination is 
widespread in several European and developing countries. OTA was reported in human milk 
in Norway, Sweden, Germany, Italy, Chile, Australia and Brazil (Scott, 2005; Munoz et al., 
2010). Since the mean concentration of OTA detected in the urine of wholly breastfed 
children (0.19 ng/mL) was essentially the same with those of the fully weaned children (0.16 
ng/mL) and partially breastfed children (0.21 ng/mL); there is no doubt that the wholly 
breastfed infants tend to have the same exposure risk as the fully weaned children. These 
findings support the possibility of dietary recommendations to women during lactation aimed 
at tentatively reducing infant exposure to this carcinogen substance.  
Furthermore, none of the target metabolites of OTA such as OT alpha and 4-OH OTA were 
detected in the urine samples. Similar findings were also reported for the Korean population 
(Ahna et al., 2010). However, as suggested by Munoz et al. (2009, 2012) interindividual 
variability in the detoxification of OTA in human urine may account for the observed 
variations in urinary OT alpha and the possibility cannot be excluded that a low rate of OTA 
detoxification is a characteristic of some populations. 
Comparing our results with other studies from different populations, in terms of 
contamination levels; the mean concentration detected in this study; 0.2 ng/mL are higher 
than the mean concentration detected in Hungary; 0.013 ng/mL (Fazekas et al., 2005), Italy; 
0.02 ng/mL (Pena et al., 2006), Bulgaria; 0.05 ng/mL and 0.168 ng/mL (Petkova-Bocharova 
et al., 2003) but lower than those detected in Croatia; 2.3 ng/mL (Domijan et al., 2003). The 
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highest concentration of OTA reported so far in human urine was detected in Sierra Leone 
with a range of 0.07–148 ng/mL (no mean was reported) (Jonsyn, 2000). In general 
biomonitoring studies carried out in Europe often report a high prevalence rate (>60%) of 
OTA in human urine than in studies carried out in SSA. This could be due to differences in 
dietary habits. 
 
Furthermore, dietary aflatoxin exposure of West African children has been linked primarily to 
consumption of contaminated maize and peanuts (Njobeh et al., 2010; Allen et al., 1992). 
AFB1 was not detected in any of the 220 urine samples analyzed which is contradictory with 
results earlier reported in West Africa (Gong et al., 2002; Jonsyn, 2000) where high levels of 
aflatoxin-albumin adduct was frequently detected in the serum of children. This discrepancy 
in results is due to the relatively long half-life of the AFB1-albumin adduct. The half-life of 
human albumin is ∼20 days. AFB1-albumin may theoretically accumulate following chronic 
exposure to reach levels 30-fold higher than that the levels found after a single dose. In 
contrast, urinary AFB1 excretion will tend to parallel intake over the previous few days 
(Scholl et al., 2006).  
The sampling period (March, 2012) coincided with the start of the planting season, a period 
during which peanuts and maize are not readily available at the household level, which can 
possibly explain the zero (0%) occurrence rate. Furthermore, the high limit of quantification 
for AFB1 (2 ng/mL) with the present analytical method made the possibility for trace 
detection very difficult. In a recent study by Tchana et al. (2010), conducted with 
malnourished children from Cameroon, the maximum AFB1 detected in urine of these 
children was 0.15 ng/mL. Going by these results, it can be said that the detection limit for 
AFB1 necessitate further improvement (using a more sensitive instrument) to render it more 
suitable to biomonitor AFB1 in human urine especially in populations which are not 
chronically exposed to AFB1.  
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AFM1, a hydroxylated form of AFB1 showed a 14 % occurrence rate with a significant 
difference in the mean concentration of AFM1 between the wholly breastfed and the fully 
weaned (p = 0.001). The partially breastfed were more exposed (mean concentration 1.43 
ng/mL) compared to the fully weaned children (0.282 ng/mL). From this cross-sectional 
study, it could be deduced that weaning status rather than age could be a strong determinant of 
AFM1 exposure in children of less than 5 years. Based on the facts represented herein, we 
hereby assume that the sources of AFM1 exposure could have been either from breast milk for 
the wholly breastfed children and/or complementary milk products for the partially weaned 
infants. Interestingly, in earlier studies reported by Polychronaki et al. (2008) and Gong et al. 
(2003) with Guinean and Gambian children, significantly higher urinary aflatoxin levels were 
detected with the fully weaned children compared to the partially breastfed children. This 
result differs from our present findings. The reasons for this discrepancy in results is presently 
unclear. An earlier report by Polychronaki et al. (2007) raised the possibility that urinary 
AFM1 may not only reflect ingested AFM1 originating from breast milk. On the the hand, 
very sensitive detection systems such as fluorescence detection and enzyme-linked 
immunosorbent assay (ELISA) as used in the studies of Polychronaki et al. (2008) and Gong 
et al. (2003) allowed detection at very low picogram/mL levels and hence possibly led to an 
increase in the power of their statistical prediction. It is worth noting that despite being a 
weaker carcinogen, AFM1 is as cytotoxic as AFB1 (Neal et al., 1998).  
 
Compared to other studies conducted in SSA; the levels of AFM1 detected in samples from 
Cameroon (0.06-4.7 ng/mL) were 80-fold lower than levels reported in samples from Gambia 
(0.1-374 ng/mL) (Wild et al., 1991). Studies conducted in Europe have always shown low 
urinary levels of AFM1. This is true since the parent compound (AFB1) is not a major 
contaminant in European foodstuffs as compared to dietary staples from SSA. 
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As zearalenone and its metabolites, mainly α-ZOL and β-ZOL, are potent estrogenic 
compounds and can adversely affect reproduction in laboratory and farm animals at higher 
doses, they are considered as potential endocrine disruptors (Metzler et al., 2010). ZEN, α-
ZOL and β-ZOL were detected in 8/220 (3.6%), 9/220 (4%) and 18/220 (8%) of the samples, 
respectively. 
There was no co-occurrence of α-ZOL and β-ZOL in any of the samples. This clearly 
illustrates inter-individual variability in the metabolism of ZEN. However, co-occurrence of 
ZEN and β-ZOL was detected in one sample. In this sample the ratio of ZEN to β-ZOL was 
1:4. The high frequency of occurrence of β-ZOL compared to α-ZOL in the urine samples 
confirms a similar observation that was made in one of our previous studies (Njumbe Ediage 
et al., 2012). The presence of α-ZOL in 4% of the samples is worth noting since the estrogenic 
activity of α-ZOL is greater than that of ZEN (3-4 times) and β-ZOL (10 times). Interestingly, 
the occurrence rate of ZEN and its metabolites (α-ZOL and β-ZOL) was highest in children 
from the Northwest region where there was a high frequency of maize consumption. To the 
best of our knowledge, this is the first study carried out to determine exposure of SSA 
children to ZEN and its metabolites. 
Comparing these results with the study carried out in New Jersey (USA) (Bandera et al., 
2002), the mean concentration of total ZEN (including its metabolite) was <0.21 ng/mL 
which was lower than the levels reported in this study (3.47 ng/mL). This calls for the need to 
further investigate the effect of ZEN exposure on the target population especially with respect 
to reproductive health. 
DON is a frequent contaminant of maize and maize products. Exposure of SSA children to 
DON has so far not yet been evaluated. A recent review of epidemiological data highlighted 
the possibility of DON-induced gastroenteritis, growth faltering and immunotoxicity in 
humans with as consequence a possible increase on the susceptibility to infectious diseases 
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(Pestka and Smolinski, 2005). So far, the human health consequences of DON exposure 
remain largely unexamined. Though this study failed to establish a possible association 
between DON exposure and the specific food preferences for the different agro-ecological 
regions, a 17% occurrence rate and a maximum urinary concentration of 77 ng/mL should 
raise some concern.  
The frequency of contamination of total DON reported from other European countries is often 
the double of what was obtained in this study; 31% for Spain (Rubert et al., 2011) and 33% 
for Italy (Solfrizzo et al., 2011). Exceptionally high occurrence rate of 69% and 99% was 
reported in Portugal (Cunha et al., 2011) and the United Kingdom (Turner et al., 2011) 
respectively. In the latter, the highest concentration of DON detected in the urine samples was 
78.2 ng/mL which is similar to the maximum concentration detected in this study (77 ng/mL). 
In order to determine if the tolerable daily intake (TDI) was exceeded by the child with 77 
ng/mL detectable urinary DON, the model proposed by Meky et al. (2003) was used. This 
model assumes the following (1) the concentration of DON in the morning urine samples was 
representative of the whole day (2) the average volume of urine excreted per day was 0.2 L 
(for a 15.2 kg child) (3) 35 % of the ingested DON was being excreted in urine and (4) all 
DON originated from the previous 24 h intake only. Hence the sample with the above 
mentioned concentration would translates to a TDI of 2.89 µg/kg body weight/day which 
exceeds the provisional maximum TDI of 1 µg/kg body weight/day as proposed by Scientific 
Committee on Food (SCF, 2002). This calls for appropriate measures to address this situation 
as children under the age of 5 constitute the most vulnerable group. 
Since most of the children with detectable levels of DON were either partially breastfed or 
fully weaned, it is difficult to conclude if significant levels of DON are transferred into breast 
milk. One of the detoxification metabolite of DON (DON-3-Glu) was detected in 1% (2/220) 
of the samples analyzed. 
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Just like DON, FB1, is also a most frequent contaminant of maize and maize products. Based 
on the results of our previous survey (Table 1) we anticipated a high occurrence rate of FB1 in 
the weaning foods (which normally consist of maize porridge) and hence a high incidence or 
occurrence of this analyte in the urine of these infants. However, only 11% of the samples 
analyzed were found positive for this analyte. The mean levels of FB1 detected were not 
significantly different between the different weaning categories. FB1 was detected in the urine 
of four (1.8%) children fed exclusively on breast milk with levels between (0.73-1.3 ng/mL). 
This suggest the fact that FB1 could be carried-over in human breast milk though at low 
concentrations. Studies carried out to evaluate FB1 carry-over to milk are conflicting. A few 
authors have reported low but detectable levels of FB1 in bovine milk (Maragos et al., 1994; 
Spotti et al., 2001). The lack of sufficient data on FB1 carry-over in human milk could be due 
to the lack of sensitive analytical methods for this matrix (Gazzotti et al., 2009). In this study, 
the analytical method used had as detection limit < 1ng/mL for FB1 which could be 
considered sensitive enough to detect very low concentrations of this toxin in urine. The 
levels of FB1 detected in the urine were low (mean 2.98 ng/mL) with one sample detected 
with a concentration of 48 ng/mL. Using the same model as described for DON, this translates 
to a TDI of 0.71 µg/kg bw/day which is however less than the 2 µg/kg bw/day as proposed by 
Scientific Committee on Food (SCF, 2000b). 
Data from other international studies reveal an almost negligible presence of this analyte in 
different human urine samples. In Portugal none of the 68 samples had detectable levels of 
FB1 nor FB2 (Liliana et al., 2011). Similar results were obtained from Austria (Warth et al., 
2011), Korea (Ahn et al., 2010) and Spain (Rubert et el., 2011). Data from Mexico revealed a 
74% occurrence rate with a mean urinary concentration of 0.035 ng/mL (Gong et al., 2008).  
In general very limited number of studies has been carried out to assess urinary levels of FB1. 
This can be attributed to the fact that not until recently (from 2008 onward) biomonitoring of 
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the sphinganine/sphingosine ratio was considered as a suitable biomarker to assess exposure 
to fumonisins rather than monitoring of the parent analyte (FB1). 
 
1.5 Strengths and limitations  
 
The major strengths of this study was the diversity in the age and gender distribution across 
the study group, differences in the food preferences for the different agro-ecological zones, 
the diversity in the weaning status and the differences in socio-economic status to assess 
possible correlations between mycotoxin concentrations. This is further strengthened by the 
view that almost all the different classes of mycotoxins were included (represented) in this 
study. 
A potential weakness of this study could be the relatively small sample size (n=220) which 
may have compromised the statistical prediction power of the study and may have likely 
influenced the associated statistical inference (confidence interval, standard errors, standard 
deviation, p-value). The inability to detect aflatoxins in the low pictogram/mL levels may 
have compromised the prediction power of the study design. It is therefore imperative to 
further validate this study design (for example using a very sensitive instrumentation) and re-
evaluate the associated statistical inferences with a much larger sample population. Likewise 
the inability to detect the glucuronides of DON (<2%) and ZEN might necessitate further 
investigation in order to provide possible explanations. 
1.6 Conclusion and recommendation 
 
Young children (< 5 years of age) raised in high mycotoxin contaminated regions (zones) of 
Cameroon are exposed to significant levels of multiple toxins during infancy. There was 
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sufficient evidence to suggest a possible transfer of FB1, AFM1 and OTA via breast milk to 
these children. However, since potential adverse health effects of mycotoxins in children in 
Cameroon are not well established, this study could be considered as a pilot study to raise 
awareness of the potential health consequences these young children may suffer from during a 
later stage of their lives.  
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Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
The numbers represent the different divisions that make up the different regions. 1; Ndian, 2; Manyu, 3; Fako, 4; Meme, 5; Kupe Manenguba, 6; Lebialem, 7; 
Menchum, 8; Momo, 9; Mezam, 10; Ngo-Ketunjia, 11; Bui, 12; Boyo and 13; Donga Mantung. 
Figure caption: 
Map of Cameroon showing the location of the different studied regions (Northwest and Southwest) and villages.  
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Figure caption 
 
Figure 1: Boxplots showing the distribution of seven different mycotoxins for the six different villages investigated: (a) Deoxynivalenol, (b) 
Aflatoxin M1, (c) Ochratoxin A (d) Zearalenone, (e) Beta zearalenol, (f) Fumonisin B1 without outlier (sample contaminated with  48 ng/mL), (g) 
Alpha zearalenol. 
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Table 1. Summarized data on the occurrence of mycotoxins in different dietary staples from Cameroon 
 Mean concentration (CI, 95%) (µg/kg) of mycotoxins detected in the different staples
 
 
a
Season 1 
b
Season 2 
Sample matrix Agroecological zones 
Maize HFM HFB WH Mean 
total 
HFM HFB WH Mean 
total 
Deoxynivalenol 1134 (<LOQ-
2141) 
234 (212-918) 1567(<LOQ-2741) 978 1876(<LOQ-
2411) 
459 (<LOQ-
1084) 
2341 (218-
3842) 
1559 
Fumonisin B1 1467 (75-3716) 543 (<LOQ-
1418) 
2178 (112-5412) 1396 1845 (<LOQ-
4030) 
435 (314-2841) 2654 (<LOQ-
3212) 
1645 
Fumonisin B2 1187 (112-2268) 419 (<LOQ-
843) 
987 (75-2882) 864 1895 (10-2890) 467 (<LOQ-
915) 
1567 (112-
1846) 
1309 
Fumonisin B3 398 (<LOQ-1442) 167 (75-482) 355 (65-412) 300 755 (112-2180) 489 (132-864) 336 (<LOQ-
698) 
543 
Zearalenone 168 (75-279) 191 (<LOQ-
228) 
189 (85-262) 182 165 (35-334) 174 (<LOQ-
242) 
270 (55-286) 203 
3 and 15 acetyl 
deoxynivalenol 
66 (65-231) 46 (<LOQ-187) 90 (54-170) 67 78 (<LOQ-115) 84 (<LOQ-176) 98 (<LOQ-
186) 
86 
Roquefortine C 78 (<LOQ-94) 66 (<LOQ-137) 98 (<LOQ-145) 81 81 (<LOQ-84) 89 (<LOQ-118) 103 (<LOQ-
181) 
81 
Beauvericine 162 (<LOQ-412) 151 (<LOQ- 131 (<LOQ-264) 148 111 (<LOQ-312) 141 (<LOQ- 129 (<LOQ- 127 
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384) 284) 385) 
Peanuts         
Ochratoxin A ns ns ns ns 6 (<LOQ-12) 3 (<LOQ-10) 4 (<LOQ-4) 4 
Aflatoxin B1 ns ns ns ns 78 (<LOQ-125) 58 (<LOQ-77) 61 (<LOQ-
110) 
66 
Cassava          
Aflatoxin B1 87 (<LOQ-194) 36 (<LOQ-95) 78 (6-193) 67 95 (<LOQ-125) 25 (<LOQ-32) 89 (<LOQ-
141) 
70 
Penicillic acid 71 (<LOQ-184) 27 (<LOQ-96) 35 (<LOQ-72) 44 29 (<LOQ-76) 28 (<LOQ-46) 27 (<LOQ-44) 42 
 
 
Table 2 Descriptive data for each of the villages  
 Villages 
 Villages belonging to the Northwest region Villages belonging to the Southwest province. 
 
 
Characteristic Anta Baga Bmaya Diffa BGwana Kake 
Number of children per 
village 
N=40 N=43 N=43 N=35 N=14 N=45 
CI: confidence interval. HFM: humid forest region with monomodal rainfall, HFB: humid forest region with bimodal rainfall, WH: western highland. ns: not sampled 
LOQ: limit of quantification. The LOQ for deoxynivalenol, 3+15 acetyl deoxynivalenol, fumonisin B1, fumonisin B2, fumonisin B3, zearalenone, roquefortine C, ochratoxin A, Penicillic acid and aflatoxin B1 
were 27 µg/kg, 54 µg/kg, 0.3 µg/kg, 1 µg/kg, 100 µg/kg, 27 µg/kg, 1 µg/kg, 0.3 µg/kg, 25 µg/kg, 6 µg/kg for peanuts and 1 µg/kg for cassava respectively.  
aSeason 1: July-August 2009 
bSeason 2: December-January 2010-2011 
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Age (months)
a
 37.6 (17-54) 31.3 (18-54) 37.3 (15-54) 40.1 (17-54) 41.6 (24-53) 36.1 (16-54) 
Sex (male:female) 23:17 25:18 24:19 20:15 4:10 28:17 
% of fully weaned infants 
(%) 
42 74 63 60 55 68 
% of wholly breastfed infants 
(%) 
2.27 2.73 1.82 3.18 2.27 2.73 
Maize consumption
b
 39:40 6:43 22:43 5:35 3:14 0:45 
Cassava consumption
b
 1:40 22:43 21:43 30:35 11:14 25:45 
Peanut consumption
b
 0:40 15:43 0:43 0:35 0:14 20:45 
a
Mean (95% confidence interval (CI)). 
b
Maize, cassava and peanut consumption refers to the number of  households who indicated the use of one of these staples on a weekly basis to the 
total number of households who participated for the study per village.  
 
Table 3 Prevalence of malnutrition in children based on the World Health Organization guidelines 
 
Criteria
a
 
Total Prevalence rate (%) 
Malnutrition
b
 Extreme malnutrition
c
 
Wasting and acute malnutrition (WHZ) 220 23 15 
40 
 
Underweight (WAZ) 220 37 13 
Stunting and chronic malnutrition 
(HAZ) 
220 39 24 
 
 
 
 
a 
Diagnosis of wasting based on weight for height Z-score (WHZ); underweight based on weight for age Z-score 
(WAZ); stunting based on height for age Z-score (HAZ) according to the WHO 2006 criteria. 
b
 Malnutrition is defined as less than -2 for any of the three parameters. 
 
c 
Extreme malnutrition is defined as less than -3 for any of the three parameters. 
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Table 4 Pairwise comparison of the different villages using the p-value(s) 
 
 p value 
Villages Mycotoxins 
 OTA FB1 
Diffa   
Bmanya 0.022
*
 0.05 
Baga 0.006
*
 0.903 
BGwana 0.021
*
 0.451 
Kake 0.015
*
 0.001
*
 
Anta 0.01
*
 0.641 
Bmanya   
Baga 0.679 0.110 
BGwana 0.551 0.704 
Kake 0.455 0.935 
Anta 0.308 0.534 
Baga   
BGwana 0.173 0.684 
Kake 0.061 0.008
*
 
Anta 0.435 0.234 
BGwana   
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Kake 0.807 0.213 
Anta 0.047
*
 0.345 
Kake   
Anta 0.017* 0.456 
 
*
indicates pairs for which significant
 
differences were observed (p value < 0.05). OTA: ochratoxin 
A, FB1: fumonisin B1 
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Table 5 Distribution of mycotoxin contamination by age, sex and agro-ecological zones  
Variable/category No 
Mycotoxin contamination level: geometric mean (95% CI) (ng/mL) a 
OTA AFM1 DON FB1 ZEN β-ZOL α-ZOL 
Total (n=220) 220 0.2 (0.04-2.4) 0.33 (0.06-4.7) 2.22 (0.1-77) 2.96 (0.06-48) 0.97 (0.65-5.0) 1.52 (0.02-12.5) 0.98 (0.26-1.3) 
Age group         
1-2 years old 43 0.18 (0.06-1.3) 0.46 (0.04-4.7) 1.58 (0.43-3.8) 0.36 (0.1-7.3) 1.16 (0.65-2.1) nd 0.26 
2-3 years old 54 0.18 (0.04-0.51) 0.22 (0.08-2.35) 3.94 (1.22-15.08) 2.49 (0.4-48) 1.12 (1.10-1.3) 1.31 (0.1-10.7) nd 
3-4 years old 68 0.25 (0.07-2.4) 0.71 (0.2-4.7) 2.3 (0.6-77) 0.53 (0.1-1.3) 2.38 (1.13-5) 0.64 (0.02-15.2) 0.72 (0.4-1.3) 
4-5 years old 55 0.24 (0.1-0.5) 0.37 (0.1-1.13) 2.36 (0.15-5.5) 0.29 (0.06-1.3) 1.32 (1.25-1.4) 0.93 (0.02-6.5) 0.72 (0.4-1.3) 
Gender         
male 126 0.19 (0.06-2.4) 0.57 (0.06-4.7) 3.0 (0.05-77) 0.59 (0.06-50) 0.86 (0.5-1.4) 0.76 (0.02-15.2) 0.59 (0.4-1.3) 
female 94 0.16 (0.04-0.8) 0.35 (0.1-1.8) 0.71 (0.06-3.50) 0.02 (0.02-5.7) 1.13 2.1 (1.250-4.2) 0.58 (0.26-1.3) 
Zone         
Northwest province 107 0.25 (0.1-2.4) 0.3 (0.06-4.7) 2.14 (0.1-77) 0.74 (0.1-7.3) 0.44 (0.5-5) 1.82 (0.1-15.2) 0.59 (0.26-1.3) 
Southwest province 113 0.16 (0.06-1.3) 0.36 (0.06-4.7) 2.37 (0.43-15.08) 1.49 (0.3-48) 0.86 (0.65-1.13) 0.31 (0.02-1,25) nd 
Weaning status         
Wholly breastfed 33 0.19 (0.1-0.65) 0.69 (0.6-1.2) 2.98 (0.15-10.3) 1.03 (0.73-1.3) 0.85 (0.5-1.25) 0.86 (0.02-6.5) nd 
Partially breastfed 55 0.21 (0.06-0.49) 1.43 (0.7-4.7) 4.47 (1.22-37.6) 0.91 (0.26-1.9) 0.65 1.11 (0.02 – 15.2) nd 
Fully weaned 132 0.16 (0.08-2.4) 0.28 (0.08-1.8) 3.52 (0.21-77) 0.63(0.1-50) 1.25 (1.1-1.8) 1.13 (0.23-12.5) 0.59 
 
 
aMean (95% confidence interval (CI)). OTA: ochratoxin A, AFM1: aflatoxin M1, DON: deoxynivalenol, FB1: fumonisin B1, ZEN: zearalenone, β-ZOL: beta zearalenol and α-ZOL: alpha zearalenol. nd: not 
detected. Limit of detection for OTA, AFM1, DON, FB1, ZEN, α-ZOL and β-ZOL were 0.03 ng/mL, 0.01 ng/mL, 0.04 ng/mL, 0.01 ng/mL, 0.1 ng/mL, 0.31 ng/mL, 0.01 ng/mL respectively.  
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